insights_auto
Why is AMRX down 3.18%?
Dive Deeperchevron_right
AMRX:NASDAQ
Amneal Pharmaceuticals Inc
$19.65
arrow_downward
-3.18%(-0.65) 1D
$19.65
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRX...
Open
$20.24
High
$20.53
Low
$19.53
Mkt. cap
6.84B
Avg. vol.
2.63M
Volume
3.73M
P/E ratio
41.01
52-wk high
$21.17
52-wk low
$9.56
EPS
$0.48
Beta
1.22
Shares outstanding
319.35M
No. of employees
9K
Open
$20.24
High
$20.53
Low
$19.53
Mkt. cap
6.84B
Avg. vol.
2.63M
Volume
3.73M
P/E ratio
41.01
52-wk high
$21.17
52-wk low
$9.56
EPS
$0.48
Beta
1.22
Shares outstanding
319.35M
No. of employees
9K
News stories
From web sources and news partners
AD HOC NEWS
·
14 hours ago
Amneal announces FDA approval and Amneal Pharmaceuticals stock matches its EUR 18.05 prior close
AD HOC NEWS
·
1 day ago
Amneal Pharmaceuticals stock heads into October 29 earnings
Profile
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States. Wikipedia
About Amneal Pharmaceuticals Inc
CEOChintu Patel | Chirag Patel
Employees8.7K
Founded2002
HeadquartersBridgewater, New Jersey, United States
SectorPharmaceutical industry
Websiteamneal.com